EUVIMED · CrossrefJournal
Egyptian Liver Journal
ISSN 2090-6226 · Springer Science and Business Media LLC
Latest articles
Lessons from the world’s largest hepatitis C elimination program: impact on primary liver cancer burden in Egypt: a global burden of disease analysis with 2050 projections
Real-world safety profile of resmetirom for metabolic dysfunction-associated steatohepatitis: a disproportionality analysis of FAERS reports
Biliary fascioliasis mimicking choledocholithiasis: a case series of 4 patients with emphasis on EUS and MRCP findings
Comparative prognostic performance of FIB-4, AIP, and TyG for all-cause and cardiovascular mortality in FLI-defined MASLD: a nationally representative NHANES 2011–2018 cohort study
Metabolic dysfunction-associated steatotic liver disease: the role of oxidative stress and emerging therapeutic strategies
Ultrasound-based point shear wave elastography across chronic pancreatitis severities, pancreatic ductal adenocarcinoma, and healthy control: an exploratory Egyptian cohort study
Beyond bacteria: the gut virome and cross-organ immunometabolism in MASLD and infection
P53-mediated apoptosis and topoisomerase IIα inhibition by an acridine derivative in hepatocellular carcinoma
Serum platelet-derived growth factor-BB as a noninvasive biomarker of significant liver fibrosis in patients with chronic hepatitis B: a cross-sectional study
Molecular epidemiology of hepatitis C virus and resistance to direct-acting antivirals in tuberculosis patients of Western Siberia (Tomsk Region)
Using liver fatty acid binding protein as a diagnostic marker for metabolic dysfunction and associated steatotic liver disease (MASLD) in Egyptian patients: a case-controlled study
Circulating hypermethylated RASSF1A as a possible marker of hepatocellular carcinoma in chronic hepatitis C patients
Hepatoprotective effects of curcumin against hydrogen peroxide–induced oxidative liver injury in rats
Risk factors and outcomes of prolonged mechanical ventilation following pediatric liver transplantation: a retrospective cohort study
Circulating miRNA-122 and miRNA-223 expression signatures across TNM stages of hepatocellular carcinoma in Egyptian patients: association with angiogenesis, apoptosis, and autophagy-related biomarkers
Current hepatocellular carcinoma (HCC) status in Pakistan: a systematic review
Bloodless liver resection for hepatocellular carcinoma in cirrhotic patients using Habib sealer needle
Circulating CD90 +, CD133 +, and EpCAM + peripheral blood mononuclear cell populations in experimental liver fibrosis and hepatocellular carcinoma: association with disease severity
Association between metabolic associated fatty liver disease (MAFLD) and non-alcoholic fatty pancreatic disease (NAFPD) among Egyptian patients
Serum fibroblast growth factor-19 as a diagnostic biomarker of hepatocellular carcinoma and indicator of portal vein thrombosis: a cross-sectional study
Prevalence of hereditary thrombophilia among Egyptian children with portal vein thrombosis
Establishment and validation of RNA methylation-related lncRNAs signature that predicts prognosis and potential targeted therapy in hepatocellular carcinoma
Impact of combining metformin or lifestyle modifications with direct-acting antivirals on hepatic steatosis and glycemic control in HCV prediabetic patients
Exploring the therapeutic potential of mitochondrial mechanism in metabolic dysfunction associated steatotic liver disease
A rare concurrence of hepatic and primary subcutaneous hydatid cyst
CRKL as a central mediator of anti-PD-1 immunotherapy resistance in hepatocellular carcinoma: mechanisms and therapeutic perspectives
The genetic landscape of liver cancer: stem cells, viruses and personalized treatments
The relation between MICA and COMT variants and the clinical pathological factors of hepatocellular carcinoma
Effects of epigallocatechin-3-gallate against thioacetamide-induced liver fibrosis in rats
Assessment of short-term morbidity and mortality in patients with decompensated liver disease in the Suez Canal area
EUVIMED